Amyotrophic lateral sclerosis (ALS) and the endocrine system: Are there any further ties to be explored?

Amyotrophic Lateral Sclerosis (ALS) belongs to the family of neurodegenerative disorders and is classified as fronto-temporal dementia (FTD), progressive muscular atrophy, primary lateral sclerosis, and pseudobulbar palsy. Even though endocrine dysfunction independently impacts the ALS-related survi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Alexios-Fotios A. Mentis, Anastasia M. Bougea, George P. Chrousos
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Amyotrophic lateral sclerosis Endocrinology Aging Thyroid Adrenal glands Vitamin D Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
Acceso en línea:	https://doaj.org/article/1e15cc60d549476cb898c0639cb47e88
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:1e15cc60d549476cb898c0639cb47e88
record_format	dspace
spelling	oai:doaj.org-article:1e15cc60d549476cb898c0639cb47e882021-11-10T04:40:21ZAmyotrophic lateral sclerosis (ALS) and the endocrine system: Are there any further ties to be explored?2589-958910.1016/j.nbas.2021.100024https://doaj.org/article/1e15cc60d549476cb898c0639cb47e882021-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2589958921000207https://doaj.org/toc/2589-9589Amyotrophic Lateral Sclerosis (ALS) belongs to the family of neurodegenerative disorders and is classified as fronto-temporal dementia (FTD), progressive muscular atrophy, primary lateral sclerosis, and pseudobulbar palsy. Even though endocrine dysfunction independently impacts the ALS-related survival rate, the complex connection between ALS and the endocrine system has not been studied in depth. Here we review earlier and recent findings on how ALS interacts with hormones a) of the hypothalamus and pituitary gland, b) the thyroid gland, c) the pancreas, d) the adipose tissue, e) the parathyroid glands, f) the bones, g) the adrenal glands, and h) the gonads (ovaries and testes). Of note, endocrine issues should always be explored in patients with ALS, especially those with low skeletal muscle and bone mass, vitamin D deficiency, and decreased insulin sensitivity (diabetes mellitus). Because ALS is a progressively deteriorating disease, addressing any potential endocrine co-morbidities in patients with this malady is quite important for decreasing the overall ALS-associated disease burden. Importantly, as this burden is estimated to increase globally in the decades to follow, in part because of an increasingly aging population, it is high time for future multi-center, multi-ethnic studies to assess the link between ALS and the endocrine system in significantly larger patient populations. Last, the psychosocial stress experienced by patients with ALS and its psycho-neuro-endocrinological sequelae, including hypothalamic–pituitaryadrenal dysregulation, should become an area of intensive study in the future.Alexios-Fotios A. MentisAnastasia M. BougeaGeorge P. ChrousosElsevierarticleAmyotrophic lateral sclerosisEndocrinologyAgingThyroidAdrenal glandsVitamin DNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENAging Brain, Vol 1, Iss , Pp 100024- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Amyotrophic lateral sclerosis Endocrinology Aging Thyroid Adrenal glands Vitamin D Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
spellingShingle	Amyotrophic lateral sclerosis Endocrinology Aging Thyroid Adrenal glands Vitamin D Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Alexios-Fotios A. Mentis Anastasia M. Bougea George P. Chrousos Amyotrophic lateral sclerosis (ALS) and the endocrine system: Are there any further ties to be explored?
description	Amyotrophic Lateral Sclerosis (ALS) belongs to the family of neurodegenerative disorders and is classified as fronto-temporal dementia (FTD), progressive muscular atrophy, primary lateral sclerosis, and pseudobulbar palsy. Even though endocrine dysfunction independently impacts the ALS-related survival rate, the complex connection between ALS and the endocrine system has not been studied in depth. Here we review earlier and recent findings on how ALS interacts with hormones a) of the hypothalamus and pituitary gland, b) the thyroid gland, c) the pancreas, d) the adipose tissue, e) the parathyroid glands, f) the bones, g) the adrenal glands, and h) the gonads (ovaries and testes). Of note, endocrine issues should always be explored in patients with ALS, especially those with low skeletal muscle and bone mass, vitamin D deficiency, and decreased insulin sensitivity (diabetes mellitus). Because ALS is a progressively deteriorating disease, addressing any potential endocrine co-morbidities in patients with this malady is quite important for decreasing the overall ALS-associated disease burden. Importantly, as this burden is estimated to increase globally in the decades to follow, in part because of an increasingly aging population, it is high time for future multi-center, multi-ethnic studies to assess the link between ALS and the endocrine system in significantly larger patient populations. Last, the psychosocial stress experienced by patients with ALS and its psycho-neuro-endocrinological sequelae, including hypothalamic–pituitaryadrenal dysregulation, should become an area of intensive study in the future.
format	article
author	Alexios-Fotios A. Mentis Anastasia M. Bougea George P. Chrousos
author_facet	Alexios-Fotios A. Mentis Anastasia M. Bougea George P. Chrousos
author_sort	Alexios-Fotios A. Mentis
title	Amyotrophic lateral sclerosis (ALS) and the endocrine system: Are there any further ties to be explored?
title_short	Amyotrophic lateral sclerosis (ALS) and the endocrine system: Are there any further ties to be explored?
title_full	Amyotrophic lateral sclerosis (ALS) and the endocrine system: Are there any further ties to be explored?
title_fullStr	Amyotrophic lateral sclerosis (ALS) and the endocrine system: Are there any further ties to be explored?
title_full_unstemmed	Amyotrophic lateral sclerosis (ALS) and the endocrine system: Are there any further ties to be explored?
title_sort	amyotrophic lateral sclerosis (als) and the endocrine system: are there any further ties to be explored?
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/1e15cc60d549476cb898c0639cb47e88
work_keys_str_mv	AT alexiosfotiosamentis amyotrophiclateralsclerosisalsandtheendocrinesystemarethereanyfurthertiestobeexplored AT anastasiambougea amyotrophiclateralsclerosisalsandtheendocrinesystemarethereanyfurthertiestobeexplored AT georgepchrousos amyotrophiclateralsclerosisalsandtheendocrinesystemarethereanyfurthertiestobeexplored
_version_	1718440534735847424

Amyotrophic lateral sclerosis (ALS) and the endocrine system: Are there any further ties to be explored?

Ejemplares similares